Concourse Financial Group Securities’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-25
Closed -$432 – 2220
2022
Q2
$0 Sell
25
-7
-22% -$133 ﹤0.01% 2284
2022
Q1
$1K Hold
32
– – ﹤0.01% 2122
2021
Q4
$1K Hold
32
– – ﹤0.01% 2313
2021
Q3
$1K Hold
32
– – ﹤0.01% 2339
2021
Q2
$1K Hold
32
– – ﹤0.01% 2305
2021
Q1
$1K Buy
32
+3
+10% +$68 ﹤0.01% 2269
2020
Q4
$1K Buy
+29
New +$533 ﹤0.01% 2213
2020
Q2
– Sell
-64
Closed -$1.59K – 2206
2020
Q1
$2K Hold
64
– – ﹤0.01% 1912
2019
Q4
$2K Hold
64
– – ﹤0.01% 1910
2019
Q3
$1K Hold
64
– – ﹤0.01% 1677
2019
Q2
$2K Buy
+64
New +$2.01K ﹤0.01% 2017

Other funds holding PAHC

Concourse Financial Group Securities's PAHC Position: Q3 2022 in Review

Concourse Financial Group Securities sold out of Phibro Animal Health (PAHC) in Q3 2022, closing a stake of 25 shares — an estimated $432 sold.

Concourse Financial Group Securities first reported a position in PAHC in Q2 2019 and held it in 11 quarters. The position peaked at $2K in Q1 2020. 149 funds tracked by Wall St. Rank hold PAHC as of Q3 2022.

  • Concourse Financial Group Securities reported no remaining Phibro Animal Health position as of Q3 2022 after selling out during the quarter.
  • Concourse Financial Group Securities sold 25 Phibro Animal Health shares in Q3 2022, an estimated $432.
  • Concourse Financial Group Securities first reported a position in Phibro Animal Health in Q2 2019 and held it in 11 quarters.
  • Concourse Financial Group Securities's Phibro Animal Health position peaked at $2K in Q1 2020.
  • 149 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2022.

Based on Concourse Financial Group Securities's 13F filing for Q3 2022, filed 15 Nov 2022.